These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Glycoside treatment characteristics in circulatory insufficiency with inflammatory processes in the heart]. Perchikova GE Kardiologiia; 1975 Oct; 15(10):59-61. PubMed ID: 1234915 [No Abstract] [Full Text] [Related]
6. [Influence of calcium pantothenate on the cardiotonic effect of cardiac glycosides]. Masliuk VI; Polosova TA; Litvintsev VP Sov Med; 1980; (4):21-3. PubMed ID: 7384876 [No Abstract] [Full Text] [Related]
7. [Interactions between drugs used in cardiology]. Halawa B; Mazurek W Wiad Lek; 1980 Apr; 33(7):533-8. PubMed ID: 6994358 [No Abstract] [Full Text] [Related]
8. [Combined action of anti-arrhythmia agents in the cardiology clinic]. Zabela PV Farmakol Toksikol; 1986; 49(5):62-3. PubMed ID: 3770178 [TBL] [Abstract][Full Text] [Related]
9. [Clinico-electrocardiographic aspects of the use of cardiac glycosides in children]. Reznik BIa; Shidogub EN Pediatriia; 1969 Nov; 48(11):41-3. PubMed ID: 5369593 [No Abstract] [Full Text] [Related]
10. [Therapeutic experiences with proscillaridin A in decompensated heart diseases]. Verga L; Forzani GF Minerva Med; 1967 Dec; 58(96):4318-22. PubMed ID: 6083293 [No Abstract] [Full Text] [Related]
11. [Time organization of blood coagulation in patients with rheumatic heart disease involving circulation insufficiency]. Zaslavskaia RM; Logvinenko SI; Teiblium MM; Khalberg F Klin Med (Mosk); 1996; 74(8):25-9. PubMed ID: 9036201 [TBL] [Abstract][Full Text] [Related]
12. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)]. Fan-Tkhi-Ngok-Shiong Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844 [No Abstract] [Full Text] [Related]
13. [Chronic heart failure refractory to treatment and ways of controlling it]. Evil'tis AA Kardiologiia; 1982 Sep; 22(9):66-8. PubMed ID: 7143899 [No Abstract] [Full Text] [Related]
14. [Unfavorable interactions of drugs after their combined use in cardiovascular pathology]. Eliseev OM; Novikova LS; Topolianskiĭ VD Ter Arkh; 1978; 50(1):109-22. PubMed ID: 345514 [No Abstract] [Full Text] [Related]
15. [Fluid redistribution between the extracellular medium and the cells in the diuretic therapy of cardiac insufficiency]. Vinogradov AV; Sycheva IM; Zhuravleva IA Kardiologiia; 1975 Oct; 15(10):46-52. PubMed ID: 796532 [TBL] [Abstract][Full Text] [Related]
16. [New approaches to selection of an optimal method of treatment of children with rheumatic valvulitis on the basis of a prognostic table obtained with the aid of a computer]. Trufanova AV; Kuz'mina NN; Glazkova TG Pediatriia; 1979 Jun; (6):44-51. PubMed ID: 471647 [No Abstract] [Full Text] [Related]
18. [Efficacy of captopril in the treatment of patients with severe forms of chronic heart failure]. Irani RM Ter Arkh; 1986; 58(11):55-8. PubMed ID: 3547747 [TBL] [Abstract][Full Text] [Related]
19. [Dynamics of the potassium and sodium content in the erythocytes and blood plasma in rheumatic heart defects before and after treatment with cardiac glycosides and in combination with biologically active substances]. Masliuk VI; Saluén'ia AI; Smirnova GA; Burmistrova LP; Samgina TS Sov Med; 1979 Jan; (1):57-61. PubMed ID: 424863 [No Abstract] [Full Text] [Related]
20. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration]. Rosini E; Petacchi R Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292 [No Abstract] [Full Text] [Related] [Next] [New Search]